Literature DB >> 23100289

Significance of tumour vessel invasion in determining the morphology of isolated tumour cells in the pulmonary vein in non-small-cell lung cancer.

Soichiro Funaki1, Noriyoshi Sawabata, Abulimiti Abulaiti, Tomoyuki Nakagiri, Yasushi Shintani, Masayoshi Inoue, Masato Minami, Meinoshin Okumura.   

Abstract

OBJECTIVES: The existence of clustered isolated tumour cells (ITCs) in the pulmonary vein (PV) of the lungs of patients with lung cancer has been reported to be a prognostic factor. However, the clinical-pathological characteristics related to their presence in the PV remain unclear.
METHODS: We analysed the surgical results and clinical-pathological findings of 130 patients who underwent surgery for non-small-cell lung cancer in regard to blood vessel invasion (BVI), serum carcinoembryonic antigen (CEA) level, maximum standardized uptake value (SUV-max), size of the solid region in computed tomography findings and pathological stage according to an ITC type, i.e. no tumour (N), singular tumour cells (S) and clustered tumour cells (C).
RESULTS: ITCs were detected in 96 (74%) of the patients, with C observed in 43, S in 53 and N in 34. Recurrence was seen in 33 (26%) cases, 21 of which were classified as C, 9 as S and 3 as N. The disease-free survival rate was significantly worse in C cases when compared with the others (P < 0.01). The rate of C was high in cases with high serum CEA, advanced p-staging and positive BVI ratio. Furthermore, BVI positive and ITC morphology were strongly related (BVI positive; 79 in C, 40 in S, 9% in N; P < 0.01).
CONCLUSIONS: Clustered ITCs were shown to be a prognostic indicator and strongly related to BVI. Our results suggest that determination of BVI has prognostic value, as clustered ITCs with metastatic potential are disseminated from the invaded vein.

Entities:  

Keywords:  Blood vessel invasion; Isolated tumour cells; Non-small-cell lung cancer; Recurrence; Surgery

Mesh:

Year:  2012        PMID: 23100289     DOI: 10.1093/ejcts/ezs553

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

1.  PD-L1 Expression on Lung Cancer Stem Cells in Metastatic Lymph Nodes Aspirates.

Authors:  Agata Raniszewska; Małgorzata Polubiec-Kownacka; Elzbieta Rutkowska; Joanna Domagala-Kulawik
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

2.  Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.

Authors:  Vasudha Murlidhar; Rishindra M Reddy; Shamileh Fouladdel; Lili Zhao; Martin K Ishikawa; Svetlana Grabauskiene; Zhuo Zhang; Jules Lin; Andrew C Chang; Philip Carrott; William R Lynch; Mark B Orringer; Chandan Kumar-Sinha; Nallasivam Palanisamy; David G Beer; Max S Wicha; Nithya Ramnath; Ebrahim Azizi; Sunitha Nagrath
Journal:  Cancer Res       Date:  2017-07-17       Impact factor: 12.701

Review 3.  Circulating tumor cells versus circulating tumor DNA in lung cancer-which one will win?

Authors:  Silvia Calabuig-Fariñas; Eloísa Jantus-Lewintre; Alejandro Herreros-Pomares; Carlos Camps
Journal:  Transl Lung Cancer Res       Date:  2016-10

4.  Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer: A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis.

Authors:  Shiyou Wei; Chenglin Guo; Jintao He; Qunyou Tan; Jiandong Mei; Zhenyu Yang; Chengwu Liu; Qiang Pu; Lin Ma; Yong Yuan; Feng Lin; Yunke Zhu; Hu Liao; Wenping Wang; Zheng Liu; Qiang Li; Bin Jiang; Chuan Li; Liang Xia; Kejia Zhao; Fanyi Gan; Jiahan Cheng; Zhu Wu; Yun Wang; Yidan Lin; Yingli Kou; Guowei Che; Longqi Chen; Jing Li; Lunxu Liu
Journal:  JAMA Surg       Date:  2019-07-17       Impact factor: 14.766

5.  Does lung cancer surgery cause circulating tumor cells?-A multicenter, prospective study.

Authors:  Noriyuki Matsutani; Noriyoshi Sawabata; Masafumi Yamaguchi; Tetsukan Woo; Yujin Kudo; Akikazu Kawase; Satoshi Shiono; Hisae Iinuma; Shigeki Morita; Masafumi Kawamura
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

6.  Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?

Authors:  Noriyoshi Sawabata; Soichiro Funaki; Takeru Hyakutake; Yasushi Shintani; Ayako Fujiwara; Meinoshin Okumura
Journal:  Surg Today       Date:  2016-03-07       Impact factor: 2.549

Review 7.  Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions.

Authors:  Zhuo Zhang; Nithya Ramnath; Sunitha Nagrath
Journal:  Front Oncol       Date:  2015-09-30       Impact factor: 6.244

Review 8.  The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer.

Authors:  Joanna Kapeleris; Arutha Kulasinghe; Majid E Warkiani; Ian Vela; Liz Kenny; Kenneth O'Byrne; Chamindie Punyadeera
Journal:  Front Oncol       Date:  2018-08-14       Impact factor: 6.244

9.  Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer.

Authors:  Masaki Hashimoto; Fumihiro Tanaka; Kazue Yoneda; Teruhisa Takuwa; Seiji Matsumoto; Yoshitomo Okumura; Nobuyuki Kondo; Tohru Tsujimura; Takashi Nakano; Seiki Hasegawa
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

10.  Vein-first vs artery-first surgical technique for lobectomy of non-small cell lung cancer: A protocol for systematic review and meta-analysis.

Authors:  Lei Gao; Zhimin Shen; Hui Xu; Fei Luo; Peipei Zhang; Tianci Chai; Sui Chen; Mingqiang Kang
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.